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Background: We continue our exploration of the large polysaccharide polymer Chitosan as an acute therapy for
severe damage to the nervous system. We tested the action of subcutaneously injected nanoparticles (~ 100 – 200
nanometers in diameter; 1 mg per ml) against control injections (silica particle of the same size and concentration)
in a standardized in vivo spinal cord injury model. These functional tests used standardized physiological
measurements of evoked potentials arriving at the sensorimotor cortex subsequent to stimulation of the tibial
nerve of the contralateral hindlimb. We further explored the degree of acetylation and molecular weight of
chitosan on the success of sealing cell damage using specific probes of membrane integrity.
Results: Not one of the control group showed restored conduction of evoked potentials stimulated from the tibial
nerve of the hindleg – through the lesion – and recorded at the sensorimotor cortex of the brain. Investigation if
the degree of acetylation and molecular weight impacted “membrane sealing” properties of Chitosan were
unsuccessful. Dye - exchange membrane probes failed to show a difference between the comparators in the
function of Chitosan in ex vivo injured spinal cord tests.
Conclusions: We found that Chitosan nanoparticles effectively restore nerve impulse transmission through the
crushed adult guinea pig spinal cord in vivo after severe crush/compression injury. The tests of the molecular weight
(MW) and degree of acetylation did not produce any improvement in Chitosan’s membrane sealing properties.Background
The integrity of the cell membrane is critical for
maintaining cell physiological structure and function. For
example, immediate function loss, progressive degene-
ration, and the death of neurons after acute spinal cord
injury (SCI) is initiated after cell membrane disruption
[1-4]. Spontaneous membrane self-repair is often initiated
after the damage, but fails to overcome the overwhelming
tissue distortion and physiological derangement, such as
unregulated Ca2+ influx, reactive oxygen species (ROS)
generation, and subsequent lipid peroxidation (LPO)
(reviewed in [5] and [6]). Among all therapies, restoring
membrane integrity rapidly and effectively after injury* Correspondence: cpr@purdue.edu; cho22@purdue.edu
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reproduction in any medium, provided the orwould be critical in early stages of Central Nervous Sys-
tem (CNS) damage interfering with progressive secondary
injury [5,7-9].
It has been established that water-soluble polymers
such as polyethylene glycol (PEG) can fulfill some of the
requirements discussed above. PEG and some other
synthetic polymers rapid and effectively seal membrane
disruption [2,10]. Moreover it can preserve very signifi-
cant structural, physiological, and behavioral function
after SCI, Traumatic Brain Injury (TBI), and even loca-
lized peripheral nerve damage [2,11-13]. However, due
to the viscosity of high molecular weight (MW) and the
toxicity of low MW after the degradation of PEG, its
administration must be limited in concentration and in
timing after acute clinical neurotrauma [14,15]. Under
some circumstances PEG can be quite toxic to CNS
tissue [16-19] and see Figure Thirty one; Recovery of
Behavioral and Physiological Function In Vivo page 128
in Borgens 2003 [20]. In a parallel line of investigation,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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more significant sealing actions than PEG [21]. Actually,
the effect of chitosan, a non-toxic biodegradable polysac-
charide polymer, has already been widely studied and
used in biomedical and industrial applications, such as
beverage clarification, wound healing, surgical adhesion,
and drug delivery [22,23].
The chemical characteristics of Chitosan are mainly
determined by two variables: the degree of acetylation
(DA) (Figure 1) and MW [24]. The DA determines the
number of free amino groups in the chitosan polymer
which is inversely proportional to the degree of proton-
ation. On the other hand, the MW determines the
length of the main chain of the polymer, which poten-
tially influences the viscosity of the solution and the
shape of the polymer when it is presented in solution to
targets such as cells and tissues. Previous studies showed
that the DA plays a critical role in artificial membrane
incorporation, mammalian membrane sealing, and neuro-
physiological function restoration ex vivo [21,25-28].
Electrostatic interaction between negative charged lipid
headgroups on the cell membrane and the primary amines
on the cationic deacetylated unit, β-(1–4)-linked D-
glucosamine on the chitosan backbone has been proposed
as the major physical driving force for its membrane
adsorption and incorporation [25-27].
The effect of hydrophobic interaction between the inner
non-polar hydrocarbon chain of the membrane and the
nonionic acetylation unit, N-acetyl-D-glucosamine on
the backbone of chitosan is also claimed to complete
membrane insertion after chitosan adsorption onto the
membrane surface [25-27]. As mentioned above, MW is
closely related to the morphological structure of chitosan
presented in the aqueous solution. Previous studies sug-
gested the important role of viscosity and physical shape
of chitosan presented in chitosan aqueous solution in bio-
medical applications [29]. Furthermore we have learned
that chitosan in an injectable solution moves throughout
the systemic circulation – apparently without issueFigure 1 The chemical composition of acetylated and deacetylated ch
squared in red, is produced by the removal of the acetyl group, -COCH3, fr
deacetylation. Therefore, the amine group, squared in red, in the deacetyladependent on viscosity [21]. Thus the route of administra-
tion (Intraperitoneal, Intraveneous, or Subcutaneous) does
not appear to matter in a manner similar to PEG [10,12].
Nanoparticles and microparticles offer increased targeting
to damaged cells coincident with a corresponding de-
crease in the concentration of the polysaccharide circula-
ting within the body. Whether chitosan nanoparticles are
able to reach and repair damaged tissues as has chitosan
in aqueous solution in spinal injured animals with vascular
trauma has not been tested until this report.
In addition, the effect of MW of chitosan on membrane
organization has been discussed, mainly in the field of
artificial lipid membranes considered as a simplified cell
model. However, the issue was not settled [28,30,31]. Fang
reported the enhanced interactions of lipid bilayers with
higher MWs of chitosan, indicated by the significantly re-
duced cooperative units compared with those of lower
MWs [30]. In contrast, Quemeneur observed the inde-
pendent role of chitosan’s MW on membrane adsorption
in controlled pH environments [28].
Using these observations, we push our laboratory’s
success using Chitosan as an acutely applied membrane
“sealant” forward – and present the first functional test of
chitosan nanoparticles (100 – 200 nm diameter) appli-
cation by subcutaneous injection to adult guinea pigs with
crush/compression injury to the mid-thoracic spinal cord.
The use of nanoparticles (> 100 nm) provides a means
to deliver Chitosan in large concentrations to only the
interface of damaged cells (of course making up damaged
tissues) escaping the need to systemically deliver the poly-
mer as we have past reported. By revealing a functional
benefit to nanoparticle administration – we further tested
the “membrane repair” activity of Chitosan possessing
different degrees of acetylation and molecular weight to
determine the best composition/fabrication to move
forward with further clinical and clinically oriented studies
(Table 1). These studies used chemically modified chitosan
in solution in tests of membrane integrity. These tests
were: A) evaluating the loss of a large enzyme fromitosan. The amine group of the deacetylated chitosan (on the right),
om the acetylated chitosan (on the left) during the process of the
ted chitosan can be protonated in the acidic environment.
Table 1 Different degree of acetylation and molecular weights of chitosan in this study
Samples DA (%) MW (Da)
Molecular Weight (MW) 1 Low Low MW chitosan 15 ~ 25 100 K
2 Medium Medium MW chitosan 15 ~ 25 200 K
3 Oligo Oligo MW chitosan 15 ~ 25 5000
Degree of Acetylation (DA) 4 DAO DAO Chitosan 0
5 DA10 DA10 Chitosan 10
6 DA20 DA20 Chitosan 20
7 DA100 DA100 Chitosan 100
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of a dye molecule into the cytoplasm through compro-
mised membrane. A more extensive discussion and tech-
nical detail relative to these “dye exclusion” techniques is
detailed in [5,32]. Altogether, we pursue this line of inves-
tigation to provide a biodegradable alternative to PEG’s
use following acute Neurotrauma.
Discussion and conclusion
We provide the first preliminary results in the “whole
animal” suggesting subcutaneous injection of Chitosan
nanoparticles can dramatically improve nerve impulse
conduction through the lesion – and upwards to the
cerebral sensory centers after severe crush of mid-
thoracic spinal cord of the adult guinea pig. In the ab-
sence of this experimental therapy, conduction remained
silent. To our knowledge this is the first study of chito-
san nanofabrications in any in vivo neurotrauma model.
These data fit nicely with a previous in vitro investiga-
tion revealing a profound interference with progressive
secondary injury mechanisms in acrolein - poisoned cell
samples, membrane sealing, and the unique ability of
chitosan particles to carry a “drug cargo”. This signifi-
cantly enhances its therapeutic potential [21].
Our results reveal that Chitosan nanoparticles can in-
deed function as an important intervention in acute
spinal cord injury by ameliorating the effects of acute
compression/crush to the adult guinea pig spinal cord.
The physiological recovery of conduction shown here
frames the basis for functional recovery of motor, sen-
sory, and autonomic functioning after neurotrauma (see
discussion in [6]). However, being cautious, this promise
is not yet fulfilled until clinically meaningful recovery of
behavioral outcome measures is shown. Furthermore -
by evaluating different compositions of chitosan in con-
trolled solutions ex vivo - we do not believe MW or DA
may be a critical factor in developing this use of a safe
biodegradable polysaccharide for clinical treatment of
SCI or TBI [12]. In other words, the strong membrane
sealing effect of chitosan on damaged spinal cord tissues
occurred regardless of DA and MW. Specifically, the
TMR and LDH study confirmed the significant effect of
chitosan on inhibiting i.) the intrusion of an exogenousapplied dye into damaged spinal cord cells (P < 0.05); ii.)
as well as escape of a large endogenous enzyme LDH
through membrane defects (P < 0.05).
Membrane sealing and repair
While there may be differences in scientific nomencla-
ture between repair and sealing – those differences are
moot in the context of trauma. The exchange of ions
and macromolecules after membrane compromise is ac-
tually the initial event triggering the eventual death and
degeneration of cells after injury (reviewed by [5,6]). The
only logical means of acutely dampening and even re-
versing progressive secondary injury, cell degeneration,
localized axotomy, and the demise of neurons and their
support cells during the steady collapse of the nervous
system is to restore membrane integrity, at a minimum,
to block this exchange. This can be accomplished using
various polymers and surface – active agents we have
called membrane “sealants”. While the mechanisms of
action may vary somewhat between inorganic polymers
and polysaccharides while accomplishing this feat [32] –
the outcome is the same: the membrane defect is acutely
“plugged”; the organization of water and ions in and
around the defect is normalized; and spontaneous re-
assembly of the plasmalemma then proceeds via lipid bi-
layer components resolving into one another. In the case
of Polymers such as PEG – there is an affinity for dam-
aged membranes based on the disruption of the hydro-
philic outer leaflet. The membrane fusion is believed
mediated by a dehydration effect and volume-exclusion
aggregation of membrane lipids bringing adjacent lipids
into close physical contact [2,3,10-13,33]. With Polymers
such as Chitosan – the “reorganization” of membrane
structure is initiated, but not limited to, the edge of the
membrane defect. The subsequent continuing aggrega-
tion of chitosan on the membrane surface results from
the extended conformation of chitosan’s main chain
[25,26,28,30-32]. We hasten to add that PEG can facili-
tate a functional reconnection between proximal and
distal segments of severed axons [2,20]. This takes many
minutes of absolute immobility of the axon segments in
the presence of the polymer to accomplish this task, and
an unknown, and untested, period of immobilization of
Chen et al. Journal of Biological Engineering 2013, 7:15 Page 4 of 9
http://www.jbioleng.org/content/7/1/15the tissue for the repair to become permanent. We do
not see why chitosan would not as well induce mem-
brane fusion permitting reconnection of axon segments
in an experimental setting. However, in the context of
the animal or human suffering from neurotrauma –
such immobility would be impossible so this mechanism
of action for any polymer-based sealant is a moot point.
The issue of the degree of acetylation
The different degrees of acetylation represent different
strengths of electrostatic interaction between the cationic
chitosan and anionic lipids. Specifically, the lower the DA,
the higher the number of positive ions a chitosan mol-
ecule carries. In turn, the higher concentration of surface
charges on chitosan enables a more extended conform-
ation due to electrostatic repulsion among charged amines
on the chitosan backbone. Therefore, the polarity of the
molecules is greatly enhanced. Since the lipid headgroups
are negatively charged, molecules with lower DA might
have a greater opportunity to diffuse close to the mem-
brane breaches, and thus adsorb and seal the membrane
through electrostatic interactions. This mechanism is con-
sistent with previous studies in which chitosan polymers
incorporated with artificial membrane films and vesicles
where physical attractions and interactions were a result
of membrane adsorption [25,26]. Our data however, did
not reveal a hint of an improvement in function of chito-
san based on the DA.
The issue of molecular weight
Here, equivalent sealing effects using different MW chito-
san treatments was suggested in both TMR and LDHFigure 2 Quantification of normalized fluorescence intensity of TMR u
intensity in the PBS group was used as the control. Note that all chitosan t
uptake following the transection injury, *P < 0.05, ** P < 0.01 (Dunnett test)
treatments with different DA and MW, P > 0.05 (Tukey test). N = 6.tests, and in both transection and compression ex vivo
injury models. Based on the fact that different MW chito-
san in our study shared a similar DA, one possible reason
for the consistency of data found in different MW chito-
san treatments might be the predominant role of DA over
chitosan MW in initiating membrane repair. A similar
result is also observed in the zeta-potential evaluation of
the influence of different MWs of chitosan on membrane
adsorption [28].
The data shown in Figure 2 reveals that all tests showed
a statistically significant reduction in TMR fluorescent
intensity. There was little difference between them how-
ever - with the exception of DA100 which revealed a pos-
sible lower capability for sealing. An alternative thought is
that the MW could play a role in membrane sealing
[30,31] as it is closely related with the morphological
structure of chitosan presented in the aqueous solution.
Typically, the two most common structures are 1.) rope-
like and 2.) coil-like polymeric shapes. The most likely
shape in an oligo-chitosan solution would be rope-like
due to the relatively few numbers of monomers existing in
the chitosan. The less folded main chains of this polymer
require less energy to diffuse close to the cell membrane
and fit near or into its breaches. On the other hand, MW
is also proportional to the viscosity of the aqueous so-
lution, which reflects the hydrodynamic diameter of chito-
san molecules; refer back to Figures 3 and 2 [29]. The
degree of the intermingling entanglement of chitosan
polymer is proportional to the chain length, in other
words - the MW. Considering the higher MW of Medium
chitosan which is 40 times the size of the oligomer, this
might result in the reduced mobility of the polymer. Thisptake as a function of chitosan treatments. The fluorescence
reatments significantly decreased the fluorescence intensity of TMR
. A Statistical difference was not observed between chitosan
Figure 3 The fluorescence intensity of TMR uptake after transection injury and its inhibition by different chitosan treatments. A) control,
B) DA100, C) DA20, D) DA10, E) DA0, F) Oligo, G) Low, H) Medium. See test for nomenclature.
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contact area between chitosan molecules and lipids [34].
“Nanomedicine”
The superiority of nano-fabrications in particular over
aqueous suspensions of injected polymers, cannot be
under appreciated. High molecular weights of PEG are
too viscous for facile IV use. Lowering the MW in an ef-
fort to produce a clinically easy injection may produce
some level of toxicity due to the circulation of polymers
which do not degrade and must be removed at the level
of the kidney and liver (as discussed and cited above).
Chitosan, as a naturally occurring polysaccharide, is not
toxic. Detection of it in bodily fluids after systemic ad-
ministration is unlikely.
Moreover, PEG coated silica nanoparticles required the
PEG surface coat fabrication over the silica nanoparticle
which is inert. To be further useful as a targeted repair
agent and a delivery vehicle requires a third step - the
bonding of surface PEG to the drug or cytokine of choice.
In chitosan nanofabrications, the chitosan itself is the
“sealant” while capturing or surface bonding of a drug/
cytokine to be released requires only another single step
in the process. Chitosan nanospheres - by themselves -
show significant sealing properties producing improved
physiological recovery after SCI.
Results
In vivo testing
SSEP responses to injection of chitosan microspheres
As expected, and observed many times before, all 5 silica
nanoparticle – injected control animals failed to recover
any form of evoked potential (EP) by 3 weeks after com-
pression injury. The lack of conduction was confirmed
by clear recordings of EPs elicited from Median nerve“control” stimulation at the same stimulation parameters
before and after spinal compression. Of the 11 nanoparticle-
treated animal group, 3 of these died prior to the final
physiological measurement session. Instead of complica-
ting evaluation by periodic scoring, we statistically com-
pared only those animals that survived until the end of the
study. SSEP conduction recovered in every one of these
eight healthy animals. This difference between “controls
and experimentals” was strikingly statistically significant
(P = 0.007; Fisher’s exact; see Figure 4).
Enzyme leakage from injured and untreated and treated
spinal cords
The membrane sealing effect of chitosan was further
confirmed by the inhibition of leakage of the intracellular
enzyme Lactate Dehydrogenase (LDH) by specific assay
(Figure 5). The signal intensity was proportional to the
amount of LDH present in the bathing solution and in-
versely related with the condition of membrane integrity.
More than a 60% decrease of the signal intensity after all
chitosan treatments strongly indicated the sealing effect of
chitosan (P < 0.05). Similar to the Tetramethylrhodamine
(TMR) test, we did not observe any correlation with the
result and the composition (MW and DA) of chitosan.
Methods
In vivo testing
Spinal cord injury in the adult guinea pig
We have used the adult guinea pig model of crush/com-
pression injury to their mid-thoracic spinal cords for over
25 years. Extensive detail of the surgical manipulations
and aftercare of spinal–injured guinea pigs, can be found
in several previous reports (for examples see; [5,10,34,35]).
Briefly: adult female guinea pigs (300 – 400 gms; Hartley
strain) were deeply anesthetized, and a midline incision
Figure 4 Somatosensory recordings in control and injured guinea pig spinal cords. The uppermost electrical record is a sample to show
the single and averaged evoked potential as they are recorded. This record was produced by stimulation of the tibial nerve and recording the
arrival of the ascending evoked potentials (EPs) of ~ 40 msec latency at the sensory motor Cortex. The three bottom traces are single records
taken consecutively from the same uninjured animal as detailed in the text, while the top record is an average of these three. Any statistical
deviation from baseline is automatically annotated. All data presented below are such averaged signals. The left column shows records taken
from a Control animal. The right column shows records obtained from a Chitosan Nanoparticle-treated animal. Note that in both samples,
compression injury eliminated transmission of EPs through the cord. Immediately below, the clear recordings of SSEP in both animals were
obtained from Median Nerve stimulation/recording. This neural circuit from the forelimb to the sensory cortex is unaffected by injury to the
midthoracic spinal cord, and is an internal control for the functioning of the system – eliminating the likelihood of “false negatives”. Note the
appearance of weak EPs in only the Chitosan Nanoparticle – treated animal – while electrophysiological functioning in the Control animal were
absent throughout the observation period. Reading down, recordings are; A) immediately post injury, B) median nerve control, C) one week post
injury, and D) two weeks post injury. The time base is 10 msec per division, with an amplitude of 1.25 microvolts/division.
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umn. A hemi-laminectomy procedure was performed
exposing the spinal cord, and it was crushed using a la-
boratory - fabricated instrument which was basically a
forceps possessing a détente. In this way the cordcompression could be reasonably standardized between
animals – and this “consultant displacement” injury is
far superior in producing a standardized outcome than
any “constant force”/weight drop technique. Animals
were kept warm until fully recovered and moved to
Figure 5 Quantification of the normalized fluorescence intensity of LDH leakage as a function of chitosan treatments. The fluorescence
intensity in the PBS group was used as the control. Note that all chitosan treatments significantly decreased the fluorescence intensity of LDH
leakage following the compression injury, *P < 0.05 (Dunnett test). A statistical difference was not observed between chitosan treatments of
different DA and MW, P > 0.05 (Tukey test). N = 6.
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technical staff of the Center for Paralysis Research
(CPR) and Veterinary Animal Holding Facility.
The measurement of spinal cord evoked potentials in adult
guinea pig as a measure of functional recovery
This laboratory pioneered the use of Somatosensory
Evoked Potential (SSEP) recording using commercial
clinical instruments for the measurement of evoked
potentials as a means to determine conduction through
guinea pig spinal lesions. We do not evaluate SSEPs to
study the nature of subtle neurological conduction in
CNS issues – but rather to determine the presence or
absence of EP conduction relative to each animal’s pre-
operative recordings. For over a decade, we have learned
this is the most sensaive of functional tests performed to
judge the animals’ recovery from SCI. Sedated guinea
pigs were connected to a Nihon Kohden Neuropack 2
Stimulator/Recorder using subcutaneous pin electrodes.
Stimulating electrodes were inserted near the tibial
nerve of the hindleg and a separate pair near the medial
nerve of the ipsilateral foreleg.
The frequency of stimulation of the leg(s) was set
at ~ 200 HZ which would produce a clear twitching of the
very local region surrounding the stimulating electrodes.
The magnitude of the stimulation was then reduced until
such movement was nearly undetectable. Recording elec-
trodes were inserted beneath the scalp superior to the re-
gion of the sensory cortex on the contralateral side (see
the citations above for figures and for more detail). Con-
trol stimulation of the foreleg medial nerve was an excel-
lent tool to prove electrode placement (and other
variables) did not affect the recordings of ascending
Evoked Potentials (EPs). This latter neural circuit was
“above” the level of the injury to the cord. On the otherhand, SCI completely blocks such conduction to the brain
when the tibial nerve is stimulated. A recovery of EPs
recorded at the contralateral sensory cortex subsequent to
a standardized regimen of electrical stimulation of the
hindlegs was taken as a recovery of electrophysiological
function in spinal cord injured animals. Recording of nor-
mal tibial – mediated SSEPs were always performed on
each animal prior to SCI. Median nerve control proce-
dures were a part of every recording period. Replacement
or movement of electrodes was unnecessary since the
medial nerve circuit set the standard for stimulation/re-
cording, and the use of a laboratory – fabricated “tog-
gle” allowed switching between stimulations of the hind
and foreleg without touching the animal or the electrical
connections.
Construction, evaluation, and administration of chitosan
nanoparticles
We have already provided complete details of fabrication,
chemical analysis, imaging, including the loading of drugs
into nanoconstructions of Chitosan spheres as used in this
study (for examples see [21,36]). We did not perform
these analytical procedures again in this study since all
features were well standardized, understood, and reported.
The Chitosan nanospheres used here were within 100 –
200 nm in diameter, fabricated using sterile media for use in
animals, at a concentration of 1 mg of chitosan particles/ml
of injection. 1 ml of this solution was injected subcutane-
ously in the nape of the neck, within ½ hour after SCI. Con-
trol injections of sterile lactated Ringers containing silica
particles of the same dimensions and concentration were
performed in a separate set of control animals accordingly.
Only 5 control animals were studied since their use here
was identical to over 50 such saline- injected animals used
as controls in 4 individual published prior studies. Animals
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up to – and sometimes exceeding - 1 month post SCI.
All guinea pigs used in this study were handled in ac-
cordance with, and prior approval by, the Purdue Univer-
sity Animal Care and Use Committee (PACUC).
Test solutions
0.1% (w/v) chitosan solutions completely dissolved in 1%
acetic acid solution by stirring overnight. Figure 1 shows
the acetylated and deacetylated forms of chitosan which
is that of basic organic chemistry. Detail information on
these polymers is provided in Table 1. All samples were
bubbled with 95% O2/5% CO2 throughout the duration
of the experiment.
Considering membrane permeability
The membrane permeability of damaged spinal cord
segments with different treatments of different degrees of
acetylation and molecular weights of chitosan solutions was
evaluated by the interference with Tetramethylrhodamine
(TMR; 4000 MW) and the leakage of the large endogenous
enzyme Lactate Dehydrogenase (LDH, 140 kDa). The leak-
age of the relatively large molecular weight enzyme from
disrupted membrane not only indicated compromize - but
is a gauge of how severe such membrane breaches were
[21,36]. The membrane sealing effect of chitosan was
measured as a function of the leakage of LDH and the
intrusion of TMR.
Briefly, after compression injury was induced, equally
weighted segments were incubated immediately into diffe-
rent chitosan and 0.1 molL-1 Phosphate buffered saline
(PBS) solutions respectively for 15 mins. Then, all seg-
ments were quickly rinsed in PBS solution for three times
to remove any leaked LDH extracellularly. Segments were
incubated in 1 ml fresh PBS solution for additional 45 mins
to allow LDH leakage from un-repaired membrane
breaches. The level of extracellular LDH in the above
600 μl bathing solution was assayed using the TOX-7 kit
(Sigma-Aldrich, Inc, USA). Six replicates were applied in
this study. Five measurements were taken for each sample.
Measurement of TMR uptake
The membrane sealing effect of chitosan was measured by
the uptake of TMR. Briefly, immediately after transection
injury, 1-cm segments of spinal cord were incubated in
different chitosan solutions and PBS solution, respectively
for 15 mins. Then, all segments were transferred and incu-
bated in 0.1% TMR dextran solution for 15 mins in
the dark. Subsequently, segments were quickly rinsed in
0.1 molL-1 PBS solution for three times and fixed in 4%
paraformaldehyde for 5 h at 4°C in the dark. Segments
were then embedded in Tssue –Tek OCT compound,
frozen in liquid nitrogen. Sections were cut at 50 μm
thickness using a freezing microtome (Thermo Electron,Waltham, MA, USA). Sections were visualized by epi-
fluorescence on an Olympus BX61 microscope with a
standard rhodamine cube (545 nm and 590 nm of excita-
tion filter and emission filter, Olympus). The fluorescence
of white matter was quantified using Image J software
(NIH). Five sections were randomly selected from the
injury zone. Six replicates were conducted in this test.
Statistical analysis
The data is expressed as a mean ± SD. One-way ANOVA
were used for statistical analyses (SAS 9.2, SAS Institute
Inc., NC, USA). Results showing significance between
different chitosan treated groups were subjected to the
Tukey’s test. In vivo evaluations used a test of propor-
tions; Fisher’s Exact Test.
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